Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Receives Warning from Nasdaq for Failing to Maintain Minimum Share Bid Price

NEW YORK, Feb. 23 (GenomeWeb News) - Transgenomic has received a letter from the Nasdaq indicating that the company does not comply with the $1 minimum bid price requirement, the company announced today.

 

According to the letter, which was received Feb. 15, Transgenomic has until Aug. 14 to regain compliance. The share price must close at or above $1 for 10 consecutive days, though Nasdaq may require the company to maintain that closing price for a longer period before determining compliance.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.